These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6994772)

  • 1. Effect of guanfacine on vigilance.
    Heidbreder E; Pagel G; Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):169S-172S. PubMed ID: 6994772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemodynamics in hypertensive patients before and during guanfacine treatment.
    Schäfer N; Rauh J; Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of guanfacine.
    Scholtysik G
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):21S-24S. PubMed ID: 6249333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centrally acting drugs in antihypertensive therapy.
    Dollery CT; Davies DS
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):5S-12S. PubMed ID: 6249334
    [No Abstract]   [Full Text] [Related]  

  • 5. An ambulatory trial of guanfacine.
    Mann S; Millar Craig MW; Melville DI; Cashman PM; Raftery EB
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension.
    Manhem P; Hökfelt B
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6994763
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of guanfacine on blood pressure and renin activity in hypertensive patients.
    Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):91S-96S. PubMed ID: 6994787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension.
    Nami R; Bianchini C; Fiorella G; Chierichetti SM; Gennari C
    J Cardiovasc Pharmacol; 1983; 5(4):546-51. PubMed ID: 6193349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the vasodilator endralazine given with the antihypertensive agent guanfacine on heart rate and blood pressure of spontaneously hypertensive rats and normotensive dogs.
    Salzmann R; Gerber W; Pally C; Scholtysik G
    J Pharm Pharmacol; 1983 May; 35(5):293-8. PubMed ID: 6134797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute action of guanfacine on peripheral circulation in hypertensive patients: measurements of arterial flow of the calf and of the forefoot, of venous capacity of the calf, of the blood pressure and of the heart rate.
    Ehringer H; Berger G; Ingerle H; Konecny U; Wöss A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):115S-121S. PubMed ID: 6994764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in psychic performance with guanfacine and clonidine in normotensive subjects.
    Kugler J; Seus R; Krauskopf R; Brecht HM; Raschig A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):71S-80S. PubMed ID: 6994783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity.
    Schoeppe W; Brecht HM
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):97S-101S. PubMed ID: 6994788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive effect of guanfacine in rats].
    Nakagawa Y; Takeda K; Hashimoto T; Sakurai H; Mitomi A; Imai S; Hamamura M; Kumada M
    Nihon Yakurigaku Zasshi; 1981 Mar; 77(3):295-312. PubMed ID: 6762984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and chronic renal effects of guanfacine in essential and renal hypertension.
    Roeckel A; Heidland A
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):141S-149S. PubMed ID: 6994769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of the hypotensive effect of guanfacine.
    Magometschnigg D; Bonelli J; Gassner A; Hitzenberger G; Lenzhofer R; Kleinberger G; Pall H
    Int J Clin Pharmacol Ther Toxicol; 1982 Apr; 20(4):174-8. PubMed ID: 7042594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of two antihypertensive agents: guanfacine and guanethidine.
    Szám I; Kállay K
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):85S-87S. PubMed ID: 6994786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanfacine and clonidine: antihypertensive and withdrawal characteristics after continuous infusion and its interruption in the spontaneously hypertensive and normotensive rat.
    Thoolen MJ; Timmermans PB; van Zwieten PA
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):82-6. PubMed ID: 7050735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanfacine: effects of long-term treatment and withdrawal.
    Reid JL; Zamboulis C; Hamilton CA
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of single and multiple doses of guanfacine in essential hypertension.
    Zamboulis C; Reid JL
    Clin Pharmacol Ther; 1980 Dec; 28(6):715-21. PubMed ID: 7002428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on clonidine and guanfacine withdrawal after short term treatment in the rat.
    Barber ND; Reid JL
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):112-8. PubMed ID: 6758716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.